135 related articles for article (PubMed ID: 37954785)
1. Ovarian Serous Cystadenoma of the Epididymis: A Case Report.
Pierce DP; Chen B; Taylor L
Cureus; 2023 Oct; 15(10):e46886. PubMed ID: 37954785
[TBL] [Abstract][Full Text] [Related]
2. Paired box gene 2 is associated with estrogen receptor α in ovarian serous tumors: Potential theory basis for targeted therapy.
Wang M; Ma H
Mol Clin Oncol; 2016 Aug; 5(2):323-326. PubMed ID: 27446571
[TBL] [Abstract][Full Text] [Related]
3. Serous cystadenoma of the epididymis.
Talmon GA; Johannson SL
Urology; 2007 Aug; 70(2):372.e7-8. PubMed ID: 17826518
[TBL] [Abstract][Full Text] [Related]
4. Paratesticular cystadenomas with ovarian stroma, metaplastic serous Müllerian epithelium, and male adnexal tumor of probable wolffian origin: A series of 5 hitherto poorly recognized testicular tumors.
Michal M; Kazakov DV; Kacerovska D; Kuroda N; Lovric E; Wachter DL; Agaimy A; Hes O
Ann Diagn Pathol; 2013 Apr; 17(2):151-8. PubMed ID: 23020997
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems.
Wang J; Lin L; Parkash V; Schwartz PE; Lauchlan SC; Zheng W
Int J Cancer; 2003 Jan; 103(3):328-34. PubMed ID: 12471615
[TBL] [Abstract][Full Text] [Related]
6. The Coexistence of Two Different Epithelial Ovarian Tumors: A Rare Case.
Topaloğlu ÖF; Uysal E; Çelik ZE; Çelik Ç
Curr Med Imaging; 2022; 18(4):421-424. PubMed ID: 34503421
[TBL] [Abstract][Full Text] [Related]
7. Giant Primary Retroperitoneal Serous Cystadenoma: A Rare Entity Mimicking Multiple Neoplastic and Nonneoplastic Processes.
Chen F; Jiang K
Arch Pathol Lab Med; 2020 Apr; 144(4):523-528. PubMed ID: 31017452
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of HLA-DR antigen in serous ovarian tumors.
Tamiolakis D; Kotini A; Venizelos J; Jivannakis T; Simopoulos C; Papadopoulos N
Clin Exp Med; 2003 Sep; 3(2):113-8. PubMed ID: 14598186
[TBL] [Abstract][Full Text] [Related]
9. Coexisting ovarian serous cystadenoma with fibroma: A very unusual combination.
Balhara K; Mallya V; Khurana N; Tempe A
J Cancer Res Ther; 2023; 19(5):1474-1476. PubMed ID: 37787335
[TBL] [Abstract][Full Text] [Related]
10. Paratesticular müllerian-type papillary serous tumor in a child.
Cohen MC; Shawis R; Evans C
Pediatr Dev Pathol; 2009; 12(4):297-300. PubMed ID: 19348511
[TBL] [Abstract][Full Text] [Related]
11. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.
Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; D'argent Mathieu E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101966. PubMed ID: 33144266
[TBL] [Abstract][Full Text] [Related]
12. A Paratesticular Multicystic Tumor of the Tunica Vaginalis Testis as Rare Paratesticular Cystadenoma.
Draeger DL; Kraeft SK; Protzel C; Hakenberg OW
Urol Int; 2018; 101(2):245-248. PubMed ID: 28196363
[TBL] [Abstract][Full Text] [Related]
13. Expression of glucose transporter protein 1 and p63 in serous ovarian tumor.
Cai Y; Zhai JJ; Feng BB; Duan XZ; He XJ
J Obstet Gynaecol Res; 2014 Jul; 40(7):1925-30. PubMed ID: 25056472
[TBL] [Abstract][Full Text] [Related]
14. Serous and seromucinous infantile ovarian cystadenomas--a study of 42 cases.
Massicot R; Rousseau V; Darwish AA; Sauvat F; Jaubert F; Nihoul-Fékété C
Eur J Obstet Gynecol Reprod Biol; 2009 Jan; 142(1):64-7. PubMed ID: 18996636
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of p21WAF1/CIP1 and MDM2 characterizes serous borderline ovarian tumors.
Palazzo JP; Monzon F; Burke M; Hyslop T; Dunton C; Barusevicius A; Capuzzi D; Kovatich AJ
Hum Pathol; 2000 Jun; 31(6):698-704. PubMed ID: 10872663
[TBL] [Abstract][Full Text] [Related]
16. Molecular subtypes of serous borderline ovarian tumor show distinct expression patterns of benign tumor and malignant tumor-associated signatures.
Curry EW; Stronach EA; Rama NR; Wang YY; Gabra H; El-Bahrawy MA
Mod Pathol; 2014 Mar; 27(3):433-42. PubMed ID: 23948749
[TBL] [Abstract][Full Text] [Related]
17. Metastatic serous borderline ovarian tumor in an internal mammary lymph node: a case report and review of the literature.
Chamberlin MD; Eltabbakh GH; Mount SL; Leavitt BJ
Gynecol Oncol; 2001 Jul; 82(1):212-5. PubMed ID: 11426990
[TBL] [Abstract][Full Text] [Related]
18. Incidental discovery of a giant ovarian cystadenoma.
Mounir B; Anas E; Yassine E; Abdelilah EB; Khalid EH; Bensardi F; Abdelaziz F
Ann Med Surg (Lond); 2022 Oct; 82():104698. PubMed ID: 36268316
[TBL] [Abstract][Full Text] [Related]
19. Paratesticular Serous Papillary Carcinoma of High Grade and Malignant Potential: A Rare Case with a Role for Adjuvant Therapy.
Lifton J; Ghodoussipour S; Xiao GQ; Dorff T; Loh-Doyle J; Boyd SD
Cureus; 2018 Feb; 10(2):e2188. PubMed ID: 29662727
[TBL] [Abstract][Full Text] [Related]
20. Frequency of papillary tubal hyperplasia (PTH), salpingoliths and transition from adenoma to borderline ovarian tumors (BOT): A systematic analysis of 74 BOT with different histologic types.
Horn LC; Angermann K; Hentschel B; Einenkel J; Höhn AK
Pathol Res Pract; 2017 Apr; 213(4):305-309. PubMed ID: 28238382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
